PHARMA
Eisai To Make Clinical Trial Data Publicly Available
Requests for clinical trial data will be assessed by an independent review panel and the results released will be anonymized.
Visterra & A*STAR To Bring Dengue Antibody To Clinical Trials
A*STAR's D3 has joined Visterra to bring the dengue monoclonal antibody VIS513 to proof-of-concept clinical trials.
Chinese Consortium Acquires Ambrx For Undisclosed Sum
The acquisition of Ambrx adds bio-conjugation capabilities to the WuXi PharmaTech-led consortium.
Takeda To Distribute KAKETSUKEN’s Influenza Vaccine
To meet the growing demand for seasonal flu vaccines, Takeda has added KAKETSUKEN to its list of suppliers.
GHIT Fund Deepens Support For Schistosomiasis & Leishmaniasis
An additional US$11 million has been committed to developing diagnostics and drugs for neglected tropical diseases.
Generon’s Recombinant IL-22 Receives US FDA Clearance For Phase IIa Trials
Following a successful Phase I study, Generon is moving its recombinant antibody F-652 to Phase IIa trials in collaboration with the Memorial Sloan-Kettering Cancer Center.
DKSH To Support Pfizer’s Expansion In Laos
DKSH has been appointed as Pfizer's market expansion service provider for Laos.
Prima BioMed Announces Japanese Collaboration
Prima BioMed and Japanese partners NEC and Yamaguchi University are investigating the use of an adjuvant for a potential liver cancer vaccine.
Guilin Pharma Launches Anti-Malaria Film In Africa
In partnership with the National Malaria Control Program, Guilin Pharma has produced an educational video to promote malaria prevention.
